IMCD (OTCMKTS:IMCDY – Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 30th, there was short interest totaling 239 shares, a drop of 95.3% from the September 15th total of 5,092 shares. Based on an average daily trading volume, of 12,222 shares, the short-interest ratio is presently 0.0 days.
IMCD Trading Up 1.9%
IMCDY traded up $1.04 during trading hours on Friday, hitting $56.42. The company’s stock had a trading volume of 2,218 shares, compared to its average volume of 57,293. The business’s 50-day moving average price is $55.77 and its 200-day moving average price is $53.16. IMCD has a 12 month low of $39.76 and a 12 month high of $61.56.
Wall Street Analyst Weigh In
IMCDY has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of IMCD in a research note on Thursday, July 30th. UBS Group raised IMCD to a “buy” rating in a research note on Tuesday, July 14th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, IMCD currently has an average rating of “Moderate Buy” and a consensus target price of $72.50.
IMCD Company Profile
IMCD N.V. is a global distributor and formulator of specialty chemicals and food ingredients. The company connects manufacturers of chemical products and ingredients with customers across a range of industries, providing sourcing, technical support, formulation assistance and supply-chain services.
Its products serve markets including coatings and construction, advanced materials, lubricants and fuels, personal care, pharmaceuticals, food and nutrition, and home care. IMCD also operates application laboratories and technical centers that help customers develop and adapt formulations for specific applications and regulatory requirements.
Founded in Rotterdam in 1995, IMCD has expanded through organic growth and acquisitions into a global business serving customers and suppliers across Europe, the Middle East and Africa, the Americas, and the Asia-Pacific region.
Further Reading
- Five stocks we like better than IMCD
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
Receive News & Ratings for IMCD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMCD and related companies with MarketBeat.com's FREE daily email newsletter.
